-
公开(公告)号：US20150315198A1
公开(公告)日：2015-11-05
申请号：US14703848
申请日：2015-05-04
Applicant: Global Blood Therapeutics, Inc.
Inventor： Zhe Li , Qing Xu , Chul Yu , Calvin Yee , Stephen L. Gwaltney,, II , Brian W. Metcalf , Steven Richards , Matthew A. Lardy , Lina Setti , Hing Sham
IPC: C07D487/04 , C07D471/04
CPC classification number: C07D471/04 , C07D487/04 , C07D519/00
Abstract: In one aspect this invention relates generally to compounds of Formula: and sub-formulas thereof, or a tautomer of each thereof, a pharmaceutically acceptable salt of each thereof, or a pharmaceutically acceptable solvate of each of the foregoing, where X1, L1, L3, and R3 are described herein.
Abstract translation: 一方面，本发明一般涉及式及其分式，或其各自的互变异构体，其各自的药学上可接受的盐或上述各自的药学上可接受的溶剂合物，其中X1，L1，L3 和R3在本文中描述。
-
公开(公告)号：US09695166B2
公开(公告)日：2017-07-04
申请号：US14703848
申请日：2015-05-04
Applicant: Global Blood Therapeutics, Inc.
Inventor： Zhe Li , Qing Xu , Chul Yu , Calvin Yee , Stephen L. Gwaltney, II , Brian W. Metcalf , Steven Richards , Matthew A. Lardy , Lina Setti , Hing Sham
IPC: C07D471/04 , C07D487/04 , C07D519/00 , A61K31/437 , A61K31/4162
CPC classification number: C07D471/04 , C07D487/04 , C07D519/00
Abstract: In one aspect this invention relates generally to compounds of Formula: and sub-formulas thereof, or a tautomer of each thereof, a pharmaceutically acceptable salt of each thereof, or a pharmaceutically acceptable solvate of each of the foregoing, where X1, L1, L3, and R3 are described herein.
